CURE® San Antonio Breast Cancer Symposium Conference Report

Experts discuss breast cancer treatment updates at the 2020 San Antonio Breast Cancer Symposium virtual conference.

Chemotherapy With Endocrine Therapy Shows Clinical Benefit With Improved Survival in Breast Cancer

December 12, 2020

Web Exclusives

Premenopausal women with HR-positive, HER2-negative, lymph node-positive breast cancer and a risk for recurrence experienced benefits with chemotherapy plus endocrine therapy, with improvements in five-year invasive disease-free and overall survival.

Verzenio Continues to Show Reduced Risk in Invasive Disease-Free Survival in High-Risk Early HR+ Breast Cancer

December 11, 2020

Web Exclusives

In this phase 3 trial, Verzenio with endocrine therapy reduced the risk for invasive disease recurrence and death versus endocrine therapy alone for patients with high-risk, early hormone receptor–positive, HER2-negative breast cancer.

Meditation, Survivorship Classes Significantly Reduced Depressive Symptoms in Young Breast Cancer Survivors

December 10, 2020

Web Exclusives

Prior to receiving behavioral interventions, more than half of participating young survivors of breast cancer were considered clinically depressed. That number dropped to 30% after participants received mindfulness meditation and survivorship education classes.

Dietary Changes to Reduce Diabetes Risk May Also Increase Survival for Breast Cancer

December 10, 2020

Web Exclusives

Women with higher diet adherence scores after diagnosis had a 33% lower risk for all-cause mortality and a 17% lower risk for mortality related to breast cancer compared with women with lower diet adherence scores.